Royalty Pharma plc (RPRX) 8-K Summary

This Form 8-K, dated November 5, 2025, serves primarily to announce the release of quarterly financial results.

Key Event: Financial Results

• Item 2.02: Royalty Pharma released its financial results for the quarter ended September 30, 2025.
• The detailed results are furnished via Exhibit 99.1 (the press release).
• Investor Note: Information furnished under Item 2.02 is not deemed “filed” for Section 18 liability purposes.

Key Details

• Registrant: Royalty Pharma plc (England and Wales).
• **Trading Symbol